Cord Blood America, Inc.
Cord Blood America, Inc.(CBAI), through its wholly owned subsidiary CorCell Companies, Inc., is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy.
The umbilical cord which, at birth, traditionally has been thrown away, contains a rich store of stem cells. Cryogenically preserved umbilical cord stem cells have already been used to treat 75 major diseases, including leukemia, severe anemia, metabolic blood disorders and immune deficiencies. This list is guaranteed to grow as medical research learns more about the incredible healing power of stem cells.
There is uniformity in the belief that stem cells will play a key role in fighting disease as we move forward through this century. Some scientists are confident that stem cells will launch a new era in medicine, perhaps even curing some of our most intractable diseases.
CBAI Stock Info
- Cord Blood America: Update on Stem Cells Uses
- CBAI Salutes Time Magazine
- Inside the Strange Science of Cord Blood Banking
- Stem Cells used to treat heart damage